Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short treatment options are important.
Dual Modality Treatment Solution for Dermatologists to be Featured at ASMS Annual Meeting in Houston
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will feature Radiant Aura at the American Society for Mohs Surgery (ASMS) Fundamentals of Mohs Surgery Annual Meeting, November 14-17, 2024 at the Royal Sonesta Galleria, Houston, TX.
